Mayne Pharma Group Limited (ASX: MYX) – New acquisition and agreement

The generic Efudex’ (fluorouracil cream 5%) acquisition from Spear Pharmaceuticals, Inc., comprising of US$16.0 million in cash and US$4.0 million in Mayne Pharma equity for the total of US$20.0 million, plus contingent payments of up to US$10.0 million, has been … Continue reading Mayne Pharma Group Limited (ASX: MYX) – New acquisition and agreement